Daily non-political popular news in brief.
Paving the way for future pan-European clinical trials
10-09-2007 · EurekAlert!Pan-European collaboration is important for many clinical trials and essential for trials that are investigating treatments for rare diseases. That was the message delivered today by the European Medical Research Councils, the membership organization for medical research councils across Europe based at the European Science Foundation in Strasbourg, which is coordinating two trials in rare diseases, and about to launch a review of how best to implement clinical trials that are initiated by investigators.
Read more »
Keywords: paving, way, future, pan-european, clinical, trials, pan, european, trial
« Previous | Next »
Similar news on "Paving the way for future pan-European clinical trials":
- Taking the wraps off drug safety data from clinical trials
03-06-2007 · EurekAlert!
A new analysis by researchers at the Harvard School of Public Health (HSPH) and Brigham and Women's Hospital (BWH) of laws and regulations governing public disclosure of clinical trial data submitted to the Food and Drug Administration suggests changes should be made to the way the FDA implements its policy regarding the confidentiality of those data.
Similar news · Read more »
- Minimally invasive device shows promise in treating female urinary incontinence
05-22-2007 · EurekAlert!
A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.
Similar news · Read more »
- Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of The Lancet.
Similar news · Read more »
- Conflicting attitudes hinder participation in clinical trials
02-01-2007 · EurekAlert!
Women have conflicting attitudes about participating in clinical trials because of uncertainties about trusting the experimenters, fear of the trial itself and hope that the research will result in medical progress, according to a new study at Wake Forest University School of Medicine.
Similar news · Read more »
- First clinical trial of gene therapy for childhood blindness
05-01-2007 · EurekAlert!
The first clinical trial to test a revolutionary treatment for blindness in children has been announced by researchers at UCL (University College London). The trial, funded by the Department of Health, is the first of its kind and could have a significant impact on future treatments for eye disease.
Similar news · Read more »
- From clinical cancer research: rethinking therapeutic cancer vaccine trials
07-03-2007 · EurekAlert!
Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
Similar news · Read more »
- Rutgers biomaterial debuts in clinical trials of new stent
10-18-2007 · EurekAlert!
A revolutionary, new biomaterial, developed at the New Jersey Center for Biomaterials at Rutgers University, has moved from the lab bench to field testing in record time. This achievement, a product of a breakthrough methodology in biomaterials discovery, is the enabling technology behind a coronary stent undergoing its first-in-human clinical trial in Germany and in Brazil.
Similar news · Read more »
- Clinical Trials Directive still hampering academic medical research
09-27-2007 · EurekAlert!
The Clinical Trials Directive, which came into force in May 2004 in order to create a harmonized framework for clinical drug research across Europe, is still hampering such research, according to new findings presented at the European Cancer Conference.
Similar news · Read more »
- Drug based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of the Lancet.
Similar news · Read more »
- Helping muscle regenerate
11-01-2006 · EurekAlert!
Blocking a central signal molecule, researchers from the Mouse Biology Unit of the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, have found a way to protect muscle from degenerating after injury and to improve muscle healing in mice. The study appears in the current issue of the Journal of Clinical Investigation and suggests molecules with potential to speed up the regeneration of damaged muscle as promising drug targets for new therapies against muscle wasting.
Similar news · Read more »
